Cite
HARVARD Citation
Giraud, R. et al. (2021). Timing of VV‐ECMO therapy implementation influences prognosis of COVID‐19 patients. Physiological reports. 9 (3), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Giraud, R. et al. (2021). Timing of VV‐ECMO therapy implementation influences prognosis of COVID‐19 patients. Physiological reports. 9 (3), p. n/a. [Online].